Table 1.
Hepatic content of reduced glutathione (GSH) and malondialdehyde (MDA)
| Parameter | Group | ||||
|---|---|---|---|---|---|
| Normal control (N) | DENA control (D) | Lawsonia (L) | Octreotide (O) | Octreotide + lawsonia (L + O) | |
| GSH content (µM/500 mg) wet tissue | 3.3 ± 0.2 | 1.311 ± 0.08727a | 2.188 ± 0.0999a | 1.804 ± 0.1309b | 2.758 ± 0.1033a |
| MDA content (µM/500 mg) wet tissue | 29.1 ± 1.7 | 148.6 ± 9.8a | 92.85 ± 8.9a | 113.6 ± 8.6b | 54.08 ± 5a |
Data are presented as mean ± SE, n = 10, multiple comparisons were done using one-way ANOVA followed by Tukey–Karmer as post ANOVA test
D DENA, L LIE, O OC, L + O LIE + OC
aHighly significantly different from corresponding control at P < 0.001
bSignificantly different from control group at P < 0.05, D group was compared to normal control, L, O and L + O groups were compared to DENA control